| Model | PLQ | p valuea |
---|
Total | Model 1 | 1.93 (1.32-3.01) | <0.001 |
Model 2 | 1.86 (1.31-2.95) | <0.001 |
Model 3 | 1.82 (1.28-2.94) | <0.001 |
Model 4 | 1.81(1.24-2.82) | <0.001 |
Model 5 | 1.76 (1.22-2.77) | 0.005 |
men | Model 1 | 2.13 (1.41-3.69) | <0.001 |
Model 2 | 2.02 (1.50-3.57) | <0.001 |
Model 3 | 1.91 (1.32-2.88) | <0.001 |
Model 4 | 1.83(1.27-2.85) | <0.001 |
Model 5 | 1.81 (1.25-2.83) | <0.001 |
women | Model 1 | 1.88 (1.29-3.12) | <0.001 |
Model 2 | 1.84 (1.27-2.99) | <0.001 |
Model 3 | 1.80 (1.24-2.98) | <0.001 |
Model 4 | 1.79(1.22-2.92) | <0.001 |
| Model 5 | 1.75 (1.19-2.85) | 0.008 |
- Values are ORs (95% CI).
- Model 1: Unadjusted. Model 2: Adjusted for age, sex, smoking (yes/no), alcohol drinking (yes/no), family history of diabetes (yes/no). Model 3: Further adjusted for waist circumference, HOMA-IR, BMI and waist/hip ratio. Model 4: Further adjusted for serum triacylglycerol, total cholesterol, HDL- and LDL-cholesterol. Model 5: Further adjusted for inflammatory factors (CRP) and treatments (including antihypertensive therapy, antihyperlipidemic therapy and antihyperglycemic therapy). aFor the risk of PLQ, we defined subjects with no carotid atherosclerotic plaques as 0, and carotid atherosclerotic plaques as 1 from the analysis.